News for Arix Bioscience plc (ARIX.L)

Published at

Jul 16, 2025 12:47 PM

by gurufocus.com

positive

positive

PureTech Announces Leadership Transition | PRTC Stock News

PureTech Health plc (PRTC) announces the departure of CEO Bharatt Chowrira as Robert Lyne takes on the role of Interim CEO. Lyne assumes leadership with

PTCHF PRTC.L PRTC ARIX.L

Read more →
Published at

Jul 16, 2025 10:00 AM

by gurufocus.com

mixed

mixed

PureTech Announces Leadership Transition

[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the li

ARIX.L PTCHF PRTC.L PRTC

Read more →
Published at

May 10, 2024 8:48 PM

by gurufocus.com

positive

positive

Acacia Research Corp (ACTG) Reports Mixed Q1 2024 Results Amid Strategic Shifts

Revenue: Reported $24.3 million, significantly up from $14.8 million in the previous year, surpassing the estimated $22.00 million.Net Loss: Recorded a GAAP ne

ARIX.L ACTG

Read more →
Published at

Mar 14, 2024 10:35 PM

by gurufocus.com

positive

positive

Acacia Research Corp (ACTG) Reports Significant Revenue Growth and Strategic Acquisitions in Q4 2023

Revenue Surge: Q4 consolidated revenue jumped to $92.3 million from $13.1 million in the same quarter last year.Intellectual Property Success: Intellectual pro

ARIX.L

Read more →
Published at

Feb 12, 2024 8:46 PM

by marketscreener.com

mixed

mixed

Katoro Gold launches fundraising, eyes board shake-up

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- Metals One PLC - Finland and Norway-focused developer of...

POW.L MTR.L MTR.AX KMK.L KAT.L BOIL.L ATY.L ARIX.L POLB.L

Read more →
Published at

Feb 12, 2024 8:00 AM

by markets.businessinsider.com

positive

positive

Suspension of Trading in Shares

Arix Bioscience PLC (ARIX) Suspension of Trading in Shares 12-Feb-2024 / 07:00 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATI...

ARIX.L

Read more →
Published at

Dec 3, 2023 10:10 AM

by seekingalpha.com

mixed

mixed

Acacia Research: Starting To Execute Its New Strategy - I Remain Bullish (NASDAQ:ACTG)

About a year after recapitalization plan announcement, Acacia finally started to execute its new investment strategy. See why I remain bullish on ACTG stock.

ARIX.L ACTG

Read more →
Published at

Nov 14, 2023 3:48 PM

by insidermonkey.com

positive

positive

Acacia Research Corporation (NASDAQ:ACTG) Q3 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Acacia Research Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this conference is being recorded.

ARIX.L ACTG

Read more →
Published at

Nov 14, 2023 11:34 AM

by investing.com

positive

positive

Earnings call: Acacia Research posts Q3 results, acquires stake in Benchmark Energy, and announces share repurchase program By Investing.com

Earnings call: Acacia Research posts Q3 results, acquires stake in Benchmark Energy, and announces share repurchase program

ATCO ARIX.L ACTG

Read more →
Published at

Nov 14, 2023 1:44 AM

by seekingalpha.com

positive

positive

Acacia Research Corporation (ACTG) Q3 2023 Earnings Call Transcript

Acacia Research Corporation (NASDAQ:NASDAQ:ACTG) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ETCompany ParticipantsJeff Stanlis - FNK IRMJ...

ARIX.L ACTG

Read more →
Published at

Nov 13, 2023 10:55 PM

by gurufocus.com

positive

positive

Acacia Research Corp (ACTG) Reports Mixed Q3 Results Amid Strategic Shifts

Acacia Research Corp (ACTG) reported a decrease in consolidated revenue to $10.1 million for Q3 2023 compared to $15.9 million in Q3 2022.The company recorded

ARIX.L

Read more →
Published at

Nov 1, 2023 1:20 PM

by marketscreener.com

positive

positive

RTW Biotech agrees "immediately accretive" Arix Bioscience takeover

RTW Biotech Opportunities Ltd on Wednesday said it has agreed to acquire all the assets of fellow London listing Arix Bioscience PLC in exchange for new RTW shares, and to buy a 25.5% stake from...

ARIX.L

Read more →
Published at

May 23, 2023 4:05 PM

by marketscreener.com

mixed

mixed

North Atlantic Smaller Investment Trust : Annual Report and Accounts for the year ended 31 January 2023

North Atlantic Smaller Companies Investment Trust plc Annual Report for the year ended 31... | May 23, 2023

NAS.L ARIX.L

Read more →
Published at

Mar 1, 2023 6:00 AM

by ft.com

mixed

mixed

Healthcare could provide a tonic for bears and bulls alike

Data businesses and medical equipment suppliers are riding long-term trends such as ageing

WWH.L PCGH.L MSCL.SN IBT.L HTIA ARIX.L SNEX SGEN HCSG

Read more →
Published at

Oct 6, 2021 8:01 AM

by marketscreener.com

mixed

mixed

MarketScreener

Arix Bioscience PLC Board Changes 06-Oct-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this... | October 6, 2021

TEAM.L HVPE.L BHGU.L BHGG.L ARIX.L 0A18.L

Read more →
Published at

Feb 11, 2021 9:00 AM

by prnewswire.com

neutral

neutral

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

/PRNewswire/ -- Artios Pharma Limited ("Artios"), a leading DNA Damage Response (DDR) company developing a broad pipeline of precision medicines for the...

MRK1N.MX MRK.SG MRK.MU MRK.F MRK.DE MRK.BE MKGAF IPO.L IOOA.F ARIX.L 3HY.F

Read more →
Published at

Feb 11, 2021 9:00 AM

by markets.businessinsider.com

neutral

neutral

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

- Artios Pharma transitions to a clinical-stage precision medicine company - Advances next generation DNA Damage Response (DDR) treatment targetin...

MRK1N.MX MRK.SG MRK.MU MRK.F MRK.DE MRK.BE MKGAF IPO.L IOOA.F ARIX.L 3HY.F

Read more →
Published at

Feb 11, 2021 9:00 AM

by markets.businessinsider.com

neutral

neutral

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

CAMBRIDGE, England and NEW YORK, Feb. 11, 2021 /PRNewswire/ -- Artios Pharma Limited ('Artios'), a leading DNA Damage Response (DDR) company devel...

MRK1N.MX MRK.SG MRK.MU MRK.F MRK.DE MRK.BE MKGAF IPO.L IOOA.F ARIX.L 3HY.F

Read more →
Published at

Jan 18, 2021 5:46 PM

by marketscreener.com

mixed

mixed

Proactive news headlines: Oriole Resources, Faron Pharma, One Media iP Group, IQGeo Group …

Oriole Resources PLC has updated investors on the current work programmes on its West African projects during the first quarter of 2021. In Senegal, IAMGOLD has completed its... | January 18, 2021

WTE.L WMELF W6M.SG W6M.F UJO.L SRES.L SBI.L S4D.F S4D.BE RMS.L PERE.L OMIP.L NQMLF KYYWF KWS.L KS3.F KS3.BE IQG.L IPO.L IOOA.F FARN.L CMCL.L CMCL BBH.L ARIX.L ARBKF ARB.L 9CD1.SG 9CD1.F 6J8.F 67B.SG 67B.F 3HY.F 0XP.MU 0XP.F 0XP.BE W1D.F SO4.AX S1Y.F S1Y.BE PP51.F PP51.BE PHP.L ORR.L IRR.L IMM.L GDR.L EUZ.L EUZ.JO D6M.F D6M.BE BSG.F AEXG.L AEX.V 2NQ.F 25I.MU 25I.F 25I.BE ICON.L GENL.L GEGYY GEGYF 4VL.MU 4VL.F 4VL.BE

Read more →
Published at

Jan 6, 2021 3:01 PM

by marketscreener.com

neutral

neutral

Arix Bioscience : Imara reports Phase 2a clinical trial results of -2-

Biomarker results in IMR-687+HU treated patients showed an overall increase in F-cells and HbF levels from baseline to week 24, while Hb levels did not meaningfully change. Three of the eight... | January 6, 2021

IMRA FN ARIX.L 3HY.F

Read more →